Bio Behavioral Health



The ITI-1284-101 Study

Description of trial: The ITI-1284-101 Study is for people with Alzheimer’s disease who are experiencing symptoms of agitation. Patients who are experiencing symptoms are 55 years of age or older and have at least one caregiver who will be able to support them during the study. People with symptoms of agitation may feel uneasy, tense, or irritable. Other symptoms may include restlessness, pacing, wandering angry outbursts, slamming doors or being verbally or physically aggressive to themselves or others. 

The purpose of the ITI-1284-101 Study is to look at how safe a potential new drug is and whether it works to reduce symptoms of agitation in people with Alzheimer’s disease. If you and your caregiver take part, you will be in the ITI-1284-101 Study for up to 5 months. You will be randomly assigned to take either the investigational study drug or placebo once a day. 

Location of trial:

Bio Behavioral Health

20 Hospital Drive, Suite 12 Second Floor, Toms River, NJ

Contact information:

Jillian Ryan (Clinical Recruitment Coordinator)

phone: (732) 244-2299

email: info@biobehavioralhealth.com

Website Link: https://biobehavioralhealth.com/

Bio Behavioral Health



The ITI-1284-201 Study

Description of trial: The ITI-1284-201 Study is for people with Alzheimer’s disease who are experiencing symptoms of psychosis. Patients who are experiencing symptoms are 55 years of age or older and have at least one caregiver who will be able to support them during the study. There are no drugs currently approved to treat symptoms of psychosis in Alzheimer’s disease. 

The purpose of the ITI-1284-201 Study is to look at how safe a potential new drug is and whether it works to reduce symptoms of psychosis in people with Alzheimer’s disease. If you and your caregiver take part, you will be in the ITI-1284-201 Study for up to 3.4 months. You will be randomly assigned to take either the investigational study drug or placebo once a day. 

Location of trial:

Bio Behavioral Health

20 Hospital Drive, Suite 12 Second Floor, Toms River, NJ

Contact information:

Jillian Ryan (Clinical Recruitment Coordinator)

phone: (732) 244-2299

email: info@biobehavioralhealth.com

Website Link: https://biobehavioralhealth.com/

Hackensack Meridian Health



Headband for in Home Electromagnetic

Brain Stimulation

Description of trial: Hackensack Meridian Health is conducting a clinical research study using a non-invasive device (headband type device worn 2 to 3 times per day for 15 mins) with no known side effects to treat Alzheimer's disease, Lewy Body dementia, and vascular dementia.

Location of trial:

Jersey Shore Medical Center

19 Davis Avenue, 9th Floor, Neptune, NJ

Contact information:

Christine R. Hannah (Senior Clinical Research Coordinator)

phone: (732) 776-3158

email: Christine.hannah@hmhn.org

Or

Location of trial:

Hackensack University Medical Center

650 From Road, Suite 506, Paramus, NJ

Contact Information:

Lauren Tedeschi (Clinical Research Coordinator)

phone: (551) 352-0314

email: Lauren.tedeschi@hmhn.org

Kessler Foundation

A Systematized Approach to Improve Memory

in Older Adults

Description of trial: This study investigates the effectiveness of a memory enhancement technique in adults 60 years and older. Participants are randomly assigned to either an active control group or treatment group. Both groups complete memory exercises. Participants who complete the study receive $300-$500.

Location of trial:

Kessler Foundation

120 Eagle Rock Avenue, Suite 100, East Hanover, NJ

Contact information:

Diana Maloku

phone: (973) 324-8393

email: dmaloku@kesslerfoundation.org

Website Link: www.kesslerfoundation.org



Kessler Foundation

Personalized Virtual Reality-based Training to

Improve Gait and Balance and Reduce Falls in

Older Adults with MCI

Description of trial: This study assesses the effectiveness of combining thinking tasks with walking training to improve walking and balancing ability and to reduce falls in older adults with mild cognitive impairment. Participants receive up to $150 for completing the study.

Location of trial:

Kessler Foundation

1199 Pleasant Valley Way, West Orange, NJ

Contact information:

Christian Sanchez

phone: (973) 324-3590

email: CHSanchez@KesslerFoundation.org

Website Link: www.kesslerfoundation.org

Rutgers Brain Health Institute

Herbert and Jacqueline Krieger Klein Alzheimer's

Research Center

NJ Down Syndrome Aging Study

Description of trial: Adults with Down syndrome are more likely to develop Alzheimer’s disease neuropathology as they age, but not everyone develops clinical signs of dementia. This study aims to learn why and to find early signs of brain changes related to Alzheimer’s. Study participants include adults with Down syndrome, aged 20 or older. Participants will be compensated for their time.

Location of trial:

Rutgers Institute for Health

112 Paterson Street, New Brunswick, NJ



Contact information:

Dr. Luciana Mascarenhas Fonseca 

email: luciana.fonseca@rutgers.edu



Website Link: https://adrd.rutgers.edu/



Rutgers University School of Arts and Sciences Department of Psychology

WAVE-AD Study: A Window into Auditory Vulnerability in Early Alzheimer’s Disease

Description of trial: The WAVE-AD Study is calling for individuals with or without mild cognitive impairment between the ages of 55 and 75, and who have normal hearing. The goal of the WAVE-AD study is to determine whether neural signals that we can record in your auditory system can be used to detect very early hints of neurodegeneration in the human brain that might predict the later development of Alzheimer’s Disease or related dementias (AD/ADRD). Participants must be fluent in English and able to travel to the study site on the campus of Rutgers University in Piscataway, NJ. Participants will be compensated $20/hour. 

Location of trial:

Center for Advanced Human Brain Imaging Research

Staged Research Building, 661 Hoes Ln W, Piscataway, NJ 08854



Contact information:

Elias Youssef (Study Coordinator)

phone: (848)-445-8935

email:wavead@rutgers.edu



Website Link: https://sites.rutgers.edu/wave-ad/



The Clinical Research Center of New Jersey

(The CRCNJ)

The BMS (MINDSET 2) Study

Description of trial: This study is for patients with cognitive impairment associated with Alzheimer’s disease who are 60-85. This is a placebo-controlled trial to determine if the combined KarXT + KarX-EC medication is effective with cognitive decline. 

Location of trial:

The Clinical Research Center of NJ

195 Mountain Avenue, Springfield, NJ



Contact information:

The CRCNJ

phone: (973) 850-4622

email: info@thecrcnj.com

Website Link: www.thecrcnj.com



The Clinical Research Center of New Jersey

(The CRCNJ)



The Merck Study

Description of trial: The Merck study is seeking participants 50-85 years old with Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer’s disease. The study is testing MK-2214, an anti-Tau medication, to determine if it can slow changes in the brain of people with Alzheimer’s disease.  

Location of trial:

The Clinical Research Center of NJ

195 Mountain Avenue, Springfield, NJ



Contact information:

The CRCNJ

phone: (973) 850-4622

email: info@thecrcnj.com



Or

Location of trial:

The Clinical Research Center of NJ

1144 E Ridgewood Avenue, Ridgewood, NJ

Contact information:

The CRCNJ

phone: (201) 850-4622

email: info@thecrcnj.com

Website Link: www.thecrcnj.com